Direct thrombin inhibitors in acute coronary syndromes: present and future.
Weitz
Jeffrey I
JI
McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada. jweitz@thrombosis.hhscr.org
Buller
Harry R
HR
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005337:Fibrin / Q000378:metabolism; D006801:Humans; D046911:Macromolecular Substances; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013927:Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D004791:Enzyme Inhibitors; D046911:Macromolecular Substances; D005337:Fibrin; D013917:Thrombin